SPP1 and rheumatoid arthritis: For example, a preclinical study by Xie et al. demonstrated that in a murine model of rheumatoid arthritis, only mice with high baseline OPN levels showed significant improvement in joint inflammation following anti-OPN therapy, whereas those with low OPN levels exhibited minimal response [152].